» Articles » PMID: 20609864

The Complex Clinical Picture of Beta-lactam Hypersensitivity: Penicillins, Cephalosporins, Monobactams, Carbapenems, and Clavams

Overview
Specialty General Medicine
Date 2010 Jul 9
PMID 20609864
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Beta-lactam antibiotics are the drugs most frequently involved in drug hypersensitivity reactions that are mediated by specific immunologic mechanisms. In addition to benzylpenicillin, several chemical structures belonging to 5 major subgroups can induce reactions. The most relevant structure is that of the amoxicillin molecule. Reactions belong to the 4 major mechanisms described by Coombs and Gell, whereby type IV reactions have recently been further subclassified. The most frequent reactions are type I, which are IgE mediated, and type IV, which are nonimmediate and T-cell dependent. IgE-specific antibodies may recognize the benzylpenicilloyl structure or another part of the molecule, such as the side chain, as antigenic determinants. Depending on specific recognition, subjects can be either cross-reactors or selective responders. A variety of entities exist in T-cell reactions, ranging from mild exanthema to life-threatening, severe reactions, such as Stevens-Johnson syndrome or toxic epidermal necrolysis. Diagnostic tests for IgE-mediated reactions can be done in vivo by testing skin with different penicillin determinants or in vitro by quantitating specific IgE antibodies. For nonimmediate reactions, there are also in vitro and in vivo tests, with variable degrees of sensitivity and specificity. The natural history of IgE-mediated reactions indicates that the count of specific IgE antibodies decreases over time and that results of diagnostic tests can become negative.

Citing Articles

Toxic epidermal necrolysis following heart transplantation may caused by cefoperazone sodium and sulbactam sodium.

Xiaodong Z, Min W, Liming L, Jinsong H, Xiao Q, Yuemei L J Cardiothorac Surg. 2024; 19(1):542.

PMID: 39307887 PMC: 11418188. DOI: 10.1186/s13019-024-03025-x.


Approach for delabeling beta-lactam allergy in children.

Saenz de Santa Maria R, Bogas G, LaBella M, Ariza A, Salas M, Dona I Front Allergy. 2023; 4:1298335.

PMID: 38033918 PMC: 10684789. DOI: 10.3389/falgy.2023.1298335.


Drug-induced hypersensitivity reactions in a Lebanese outpatient population: A decade-long retrospective analysis (2012-2021).

Dagher J, Antonios D, Chollet-Martin S, de Chaisemartin L, Pallardy M, Azouri H J Allergy Clin Immunol Glob. 2023; 3(1):100169.

PMID: 37876854 PMC: 10590748. DOI: 10.1016/j.jacig.2023.100169.


Don't we overestimate drug allergies in children?.

Podlecka D, Jerzynska J, Brzozowska A Int J Occup Med Environ Health. 2023; 36(5):632-642.

PMID: 37750429 PMC: 10702874. DOI: 10.13075/ijomeh.1896.02227.


Tools for Etiologic Diagnosis of Drug-Induced Allergic Conditions.

Rodriguez-Perez R, De Las Vecillas L, Cabanas R, Bellon T Int J Mol Sci. 2023; 24(16).

PMID: 37628756 PMC: 10454098. DOI: 10.3390/ijms241612577.